TY  - JOUR

T1  - Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis

JO  - British Journal of Dermatology

UR  - http://dx.doi.org/10.1093/bjd/ljad124

PY  - 2023/04/30

AU  - Flohr C

AU  - Irvine AD

AU  - Cork MJ

AU  - Simpson EL

AU  - Wollenberg A

AU  - Deleuran M

AU  - Praestgaard A

AU  - Thomas RB

AU  - Rossi AB

ED  - 

DO  - DOI: 10.1093/bjd/ljad124

PB  - Oxford University Press (OUP)

VL  - 189

IS  - 2

SP  - 238

EP  - 240

Y2  - 2024/12/22

ER  -